The Opiate Antagonist, Naltrexone, in the Treatment of Trichotillomania: Results of a Double-Blind, Placebo-Controlled Study
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Trichotillomania (TTM) is characterized by repetitive hair pulling resulting in hair loss. Data on the pharmacological treatment of TTM are limited. This study examined the opioid antagonist, naltrexone, in adults with TTM who had urges to pull their hair. Fifty-one individuals with TTM were randomized to naltrexone or placebo in an 8-week, double-blind trial. Subjects were assessed with measures of TTM severity and selected cognitive tasks. Naltrexone failed to demonstrate significantly greater reductions in hair pulling compared to placebo. Cognitive flexibility, however, significantly improved with naltrexone (P = 0.026). Subjects taking naltrexone with a family history of addiction showed a greater numerical reduction in the urges to pull, although it was not statistically significant. Future studies will have to examine whether pharmacological modulation of the opiate system may provide promise in controlling pulling behavior in a subgroup of individuals with TTM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frisch, M. B., Cornell, J., Villanueva, M., & Retzlaff, P. J. (1992) · Psychological Assessment · doi:10.1037/1040-3590.4.1.92 · Cited by 1,075
Owen, A. M., Roberts, A. C., Polkey, C. E., Sahakian, B. J., & Robbins, T. W. (1991) · Neuropsychologia · doi:10.1016/0028-3932(91)90063-e · Cited by 657
Motor Inhibition and Cognitive Flexibility in Obsessive-Compulsive Disorder and Trichotillomania
Chamberlain, S. R., Fineberg, N. A., Blackwell, A. D., Robbins, T. W., & Sahakian, B. J. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.7.1282 · Cited by 627 · cited 3×
“In light of this potentially complicated neurobiological picture of a presumed simple behavior, it is not surprising that previous studies have elicited conflicting neuropsychological profiles for individuals with TTM with one study demonstrating impaired cognitive flexibility,(22) whereas another found intact set shi…”
MethodResultOslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571
Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory
Ikemoto, S. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.02.001 · Cited by 454
The Massachusetts General Hospital (MGH) Hairpulling Scale: 1. Development and Factor Analyses
Keuthen, N. J., O’Sullivan, R. L., Ricciardi, J. N., Shera, D., Savage, C. R., Borgmann, A. S., Jenike, M. A., & Baer, L. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000289003 · Cited by 444 · cited 1×
“Subjects reported severity of TTM symptoms using the self-rated MGH-HPS, the primary outcome measure for the study.(12) Although a self-report measure, the MGH-HPS has generally been accepted as the primary outcome measure in studies of TTM.”
MethodThe Demography, Phenomenology, and Family History of 22 Persons with Compulsive Hair Pulling
Schlosser, S., Black, D., Blum, N., & Goldstein, R. (1994) · Annals of Clinical Psychiatry · doi:10.3109/10401239409148996 · Cited by 178
A cognitive comparison of pathological skin picking and trichotillomania
Grant, J. E., Odlaug, B. L., & Chamberlain, S. R. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.07.012 · Cited by 80
Self-citation
Cited by
Farhat, L. C., Olfson, E., Nasir, M., Levine, J. L. S., Li, F., Miguel, E. C., & Bloch, M. H. (2020) · Depression and Anxiety · doi:10.1002/da.23028 · Cited by 133
Pharmacotherapy for trichotillomania
Rothbart, R., Amos, T., Siegfried, N., Ipser, J. C., Fineberg, N., Chamberlain, S. R., & Stein, D. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007662.pub2 · Cited by 106
França, K., Kumar, A., Castillo, D., Jafferany, M., Hyczy da Costa Neto, M., Damevska, K., Wollina, U., & Lotti, T. (2019) · Dermatologic Therapy · doi:10.1111/dth.12622 · Cited by 51
Lee, D. K., & Lipner, S. R. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116370 · Cited by 47
Identifying standardized definitions of treatment response in trichotillomania: A meta-analysis
Farhat, L. C., Olfson, E., Li, F., Telang, S., & Bloch, M. H. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.10.009 · Cited by 32
“Data from 7 additional potentially eligible trials was unavailable due to IRB limitations (Gadde et al. 2007; Grant et al. 2009; Grant et al. 2014; Leppink et al. 2017), lack of access to data (Diefenbach et al.”
Metadata
- Authors
- Grant, J. E., Odlaug, B. L., Schreiber, L. R. N., & Kim, S. W.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2014-02
- Volume
- 34
- Issue
- 1
- Pages
- 134-138
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2066062428
- Cited by
- 74
- References
- 8
- FWCI
- 8.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Opiate Antagonist, Naltrexone, in the Treatment of Trichotillomania: Results of a Double-Blind, Placebo-Controlled Study. https://app.cochat.ai/papers/10.1097/jcp.0000000000000037
- The paper
- Grant, J. E., Odlaug, B. L., Schreiber, L. R. N., & Kim, S. W. (2014). The Opiate Antagonist, Naltrexone, in the Treatment of Trichotillomania: Results of a Double-Blind, Placebo-Controlled Study. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0000000000000037
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.